peramivir: Clinical Trials

6 trials of peramivir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 withdrawn. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Recruiting 1, Withdrawn 1
Phase 11Withdrawn 1
Phase 31Completed 1

Follow peramivir: new trials by email Literature Review of peramivir trials Research Report on peramivir

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza
Oseltamivir, Favipiravir, Zanamivir - Influenza, Influenza, Human
Phase 2RecruitingUniversity of Oxford30002023-02-222026-04-14
Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections
Peramivir - Influenza
Phase 2 / Phase 3CompletedChinese University of Hong Kong162011-02-012016-01-29
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
Peramivir, Placebo - Acute, Uncomplicated Human Influenza
Phase 2CompletedBioCryst Pharmaceuticals4052008-07-012015-02-16
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
Peramivir 200 mg, Peramivir 400 mg, Oseltamivir - Influenza
Phase 2CompletedBioCryst Pharmaceuticals1372007-07-012015-02-12
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
Peramivir 150 mg, Peramivir 300 mg, Placebo - Influenza
Phase 2CompletedBioCryst Pharmaceuticals3442007-01-012015-02-12
Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
Peramivir - Influenza
Phase 1 / Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2011-11-11

Conditions studied

Influenza, Human (5)

Sponsors

BioCryst Pharmaceuticals (3)  ·  Chinese University of Hong Kong (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of Oxford (1)

Countries

United States (4)  ·  Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  South Africa (2)  ·  Brazil (1)  ·  China (1)  ·  Hong Kong (1)  ·  Laos (1)  ·  Nepal (1)  ·  Singapore (1)  ·  Thailand (1)

Top investigators

Alain Martel, MD (1)  ·  Allan Kelly, MD (1)  ·  Balbir Chahal, MD (1)  ·  Barry Packman, MD (1)  ·  Ben Lasko, MD (1)  ·  Bernardo Ng, MD (1)  ·  Bruce Berwald, MD (1)  ·  Bruce D. Forney, MD (1)  ·  Chivers Woodruff, Jr., MD (1)  ·  Dan C Henry, MD (1)  ·  Daniel Shu, MD (1)  ·  David L. Fried, MD (1)  ·  David Parenti, MD (1)  ·  Dennis Mikolich, MD (1)  ·  Dennis Riff, MD (1)

Results publications

PMID 23111657, PMID 42520824

NIH funding

N01AI30025 (1)